IDEXX实验室 IDXX 深 沪
等待开盘 02-05 09:30:00 美东时间
642.94
+10.380
+1.64%
华盛通- 最 高647.21
- 今 开638.13
- 成交量 61.24万股
- 最 低 629.14
- 昨 收 632.56
- 总市值 513.40亿
- 52周最高 769.98
- 市盈率 静 49.15
- 换手率 0.77%
- 52周最低 356.14
- 委 比 11.98%
- 总股本 7985.13万
- 历史最高 769.98
- 量 比 0.90
- 振 幅 2.86%
- 历史最低 31.915
- 每 手 1
- 风险率 107.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅213.87%！Wave Life Sciences获Canaccord Genuity升目标价至43美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences Ltd."买入"评级，目标价从40美元升至43美元；花旗：维持Palantir Technologies"买入"评级，目标价从235美元升至260美元
02-04 12:15
Roku To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
02-03 21:57
BTIG Maintains Buy on IDEXX Laboratories, Lowers Price Target to $800
BTIG analyst Mark Massaro maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and lowers the price target from $830 to $800.
02-03 18:15
电话会总结 ｜ IDEXX(IDXX)2025财年Q4业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据IDEXX业绩会实录，以下是2025年财务业绩回顾摘要： ## 1. 财务业绩 **第四季度业绩表现：** - 总营收达到9.43亿美元，同比增长14%（报告增长）和12%（有机增长） - CAG诊断经常性收入有机增长10%，其中美国增长9%，国际市场增长12% - IDEXX VetLab消耗品收入有机增长15% - 全球参考实验室收入有机增长9% - 快速检测收入有机下降3% - 影像业务收入有机增长13% **全年业绩表现：** - 实现10%的有机收入增长 - CAG诊断经常性收入有机增长8% - 全球高端仪器装机量增长12%，包括近6,
02-03 12:17
Russell 2000 Rallies, Gold And Silver Extend Losses: What's Moving Markets Monday?
Wall Street rebounded at the start of the new month after Friday's broad sell-off, but pressure on precious metals intensified as investors reassessed the Fed outlook.
02-03 02:40
Why Is IDEXX Labs Stock Falling Today?
IDEXX beat earnings and revenue estimates, boosted by strong pet diagnostics growth, and forecast solid 2026 results as new products and higher testing support momentum.
02-03 02:05
UPDATE 1-IDEXX forecasts 2026 above estimates, but cautious clinic visit outlook weighs on shares
UPDATE 1-IDEXX forecasts 2026 above estimates, but cautious clinic visit outlook weighs on shares Adds share movement in paragraph 2, CEO comment in paragraph 3, analyst comment in paragraph 6 By Sahil Pandey Feb 2 (Reuters) - Animal diagnostics maker IDEXX Laboratories IDXX.O forecast 2026 revenue
02-03 01:04
IDEXX Laboratories shares are trading lower. The company reported Q4 financial results.
IDEXX Laboratories shares are trading lower. The company reported Q4 financial ...
02-03 00:51
BUZZ-U.S. STOCKS ON THE MOVE-Apple, ESAB, Community Bancorp
BUZZ-U.S. STOCKS ON THE MOVE-Apple, ESAB, Community Bancorp Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq seesawed between gains and losses on Monday, as
02-02 23:58
IDEXX Laboratories Publishes FY 2025 MD&A Report
IDEXX Laboratories Publishes FY 2025 MD&A Report IDEXX Laboratories Inc. reported a strong fourth quarter, highlighting exceptional execution and significant strategic progress throughout the year. The company successfully scaled multiple transformative innovations and expanded its commercial presen
02-02 23:47
